Trials / Conditions / Malignant Brain Tumor

Malignant Brain Tumor

16 registered clinical trials studyying Malignant Brain Tumor — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	ASCENT Intervention for Brain Tumor Patients NCT06099743	Massachusetts General Hospital	N/A
Withdrawn	Evaluation of the Contribution of NODDI Protocol Tractography in Brain Tumor Surgery NCT05669326	GCS Ramsay Santé pour l'Enseignement et la Recherche	N/A
Recruiting	NeuroPathways Intervention for Brain Tumor Patients NCT05976490	Massachusetts General Hospital	N/A
Recruiting	Safety Study of the Repeated Opening of the Blood-brain Barrier With the SonoCloud® Device to Treat Malignant NCT05293197	Assistance Publique - Hôpitaux de Paris	Phase 1
Terminated	Evaluation of cCeLL-Ex Vivo Confocal Microscopy for Real-time Brain Tumor Diagnosis NCT06098248	VPIX Medical	N/A
Recruiting	Clinical Applicantion of Multi-Tracer PET/MR Imaging in Neurological Disorders/Disease NCT06092125	Xuanwu Hospital, Beijing	—
Completed	Magrolimab in Children and Adults With Recurrent or Progressive Malignant Brain Tumors NCT05169944	University of California, San Francisco	Phase 1
Completed	Psychological Intervention For Brain Tumor Caregivers NCT04109209	Massachusetts General Hospital	N/A
Completed	National Wide Cross-sectional Study in Paediatric Central Nervous System Tumours in China -- the CNOG-MC001 Re NCT04351035	Xinhua Hospital, Shanghai Jiao Tong University School of Medicine	—
Terminated	Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children NCT02885324	Indiana University	Phase 2
Completed	Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects NCT02798406	DNAtrix, Inc.	Phase 2
Terminated	Rates DMBT1 ( Glycoprotein) in Sputum of CF Patients With Pseudomonas Aeruginosa NCT02880111	University Hospital, Lille	—
Completed	Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primar NCT02502708	NewLink Genetics Corporation	Phase 1
Completed	Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors NCT02052648	NewLink Genetics Corporation	Phase 1 / Phase 2
Terminated	A Computer-Based Intervention for Distance Caregivers of Parents With Advanced Cancer NCT02128373	Case Comprehensive Cancer Center	N/A
Completed	Safety Study of Tarceva in Children With Refractory and Relapsed Malignant Brain Tumors and Newly Diagnosed Br NCT00418327	Gustave Roussy, Cancer Campus, Grand Paris	Phase 1